Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orbital Diseases | 4 | 2014 | 21 | 1.140 |
Why?
|
| Orbital Neoplasms | 3 | 2014 | 21 | 0.650 |
Why?
|
| Eye Injuries | 2 | 2020 | 18 | 0.520 |
Why?
|
| Eye Diseases | 2 | 2006 | 38 | 0.510 |
Why?
|
| Fasciitis | 1 | 2014 | 30 | 0.490 |
Why?
|
| Vision Disorders | 3 | 2009 | 94 | 0.480 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 150 | 0.470 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 138 | 0.470 |
Why?
|
| Military Personnel | 3 | 2020 | 220 | 0.450 |
Why?
|
| Orbit | 2 | 2011 | 30 | 0.440 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 475 | 0.400 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 286 | 0.390 |
Why?
|
| Visual Acuity | 3 | 2020 | 236 | 0.370 |
Why?
|
| Iraq War, 2003-2011 | 2 | 2020 | 85 | 0.370 |
Why?
|
| Remission, Spontaneous | 1 | 2009 | 25 | 0.350 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2009 | 34 | 0.350 |
Why?
|
| Postpartum Period | 1 | 2009 | 67 | 0.340 |
Why?
|
| Blast Injuries | 1 | 2008 | 15 | 0.340 |
Why?
|
| Eyelid Diseases | 2 | 2004 | 7 | 0.300 |
Why?
|
| Rosacea | 1 | 2006 | 5 | 0.290 |
Why?
|
| Dermatitis, Atopic | 1 | 2006 | 17 | 0.280 |
Why?
|
| Dermatologic Agents | 1 | 2006 | 32 | 0.280 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 186 | 0.260 |
Why?
|
| Xanthomatosis | 1 | 2004 | 7 | 0.250 |
Why?
|
| Dacryocystitis | 2 | 2002 | 3 | 0.250 |
Why?
|
| Granuloma | 1 | 2004 | 21 | 0.250 |
Why?
|
| Eye Infections, Bacterial | 2 | 2002 | 15 | 0.250 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2003 | 6 | 0.230 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2003 | 77 | 0.220 |
Why?
|
| Fluorouracil | 1 | 2003 | 130 | 0.220 |
Why?
|
| Cellulitis | 1 | 2002 | 13 | 0.220 |
Why?
|
| Abscess | 1 | 2002 | 37 | 0.220 |
Why?
|
| Biopsy | 2 | 2014 | 539 | 0.210 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 1139 | 0.190 |
Why?
|
| Eye Burns | 1 | 2000 | 2 | 0.190 |
Why?
|
| Eyelids | 1 | 2000 | 11 | 0.190 |
Why?
|
| Microwaves | 1 | 2000 | 31 | 0.190 |
Why?
|
| Gadolinium | 1 | 2001 | 88 | 0.190 |
Why?
|
| Asthma | 1 | 2004 | 345 | 0.190 |
Why?
|
| Orbital Fractures | 1 | 2020 | 5 | 0.180 |
Why?
|
| Artifacts | 1 | 2001 | 125 | 0.180 |
Why?
|
| Hot Temperature | 1 | 2000 | 152 | 0.180 |
Why?
|
| Adult | 9 | 2014 | 21375 | 0.160 |
Why?
|
| Humans | 16 | 2020 | 68525 | 0.140 |
Why?
|
| Pregnancy | 2 | 2014 | 2331 | 0.140 |
Why?
|
| Trauma Severity Indices | 2 | 2008 | 80 | 0.130 |
Why?
|
| Female | 9 | 2014 | 38015 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 2323 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 2222 | 0.120 |
Why?
|
| Male | 9 | 2014 | 37281 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 1 | 2013 | 36 | 0.110 |
Why?
|
| Photorefractive Keratectomy | 1 | 2012 | 12 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 201 | 0.110 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2012 | 35 | 0.110 |
Why?
|
| Ophthalmology | 1 | 2012 | 39 | 0.110 |
Why?
|
| Palliative Care | 1 | 2014 | 271 | 0.110 |
Why?
|
| Orbit Evisceration | 1 | 2011 | 1 | 0.100 |
Why?
|
| Rectus Abdominis | 1 | 2011 | 9 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2012 | 254 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 214 | 0.090 |
Why?
|
| Free Tissue Flaps | 1 | 2011 | 67 | 0.090 |
Why?
|
| Exophthalmos | 1 | 2009 | 6 | 0.090 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2009 | 58 | 0.090 |
Why?
|
| Veins | 1 | 2009 | 68 | 0.090 |
Why?
|
| Middle Aged | 5 | 2014 | 21119 | 0.080 |
Why?
|
| Warfare | 1 | 2008 | 58 | 0.080 |
Why?
|
| Military Medicine | 1 | 2008 | 53 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2012 | 657 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2012 | 596 | 0.070 |
Why?
|
| Blindness | 1 | 2006 | 22 | 0.070 |
Why?
|
| United States | 3 | 2020 | 7335 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2020 | 7264 | 0.070 |
Why?
|
| Hip Dislocation, Congenital | 1 | 1984 | 10 | 0.060 |
Why?
|
| Tears | 1 | 2003 | 9 | 0.060 |
Why?
|
| Prognosis | 1 | 2008 | 2093 | 0.060 |
Why?
|
| Drug Eruptions | 1 | 2003 | 16 | 0.060 |
Why?
|
| Veillonella | 1 | 2002 | 2 | 0.060 |
Why?
|
| Streptococcus | 1 | 2002 | 15 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2006 | 1329 | 0.060 |
Why?
|
| Time Factors | 2 | 2013 | 4655 | 0.050 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2002 | 35 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2002 | 62 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 1984 | 261 | 0.050 |
Why?
|
| Young Adult | 2 | 2012 | 5708 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2002 | 175 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 648 | 0.050 |
Why?
|
| Tertiary Healthcare | 1 | 2020 | 6 | 0.050 |
Why?
|
| Hospitals, Military | 1 | 2020 | 13 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2001 | 143 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 951 | 0.040 |
Why?
|
| Afghan Campaign 2001- | 1 | 2020 | 78 | 0.040 |
Why?
|
| Adolescent | 2 | 2011 | 8903 | 0.040 |
Why?
|
| Incidence | 1 | 2003 | 1582 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2000 | 424 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2003 | 2356 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 1026 | 0.030 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 1993 | 37 | 0.030 |
Why?
|
| Refraction, Ocular | 1 | 2012 | 61 | 0.030 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2011 | 4 | 0.020 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2011 | 23 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2011 | 54 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 444 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 3185 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 7028 | 0.010 |
Why?
|
| Nasolacrimal Duct | 1 | 1993 | 4 | 0.010 |
Why?
|
| Dacryocystorhinostomy | 1 | 1993 | 5 | 0.010 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 1993 | 22 | 0.010 |
Why?
|